glp-1 vomiting lawsuit in louisiana Diabetes Weight Loss Drug Lawsuits Continue, MDL Requested Patients claim blindness, bowel injuries
Description
and glutaredoxin (1.36-fold, p=0.024), a thioltransferase thought to provide an antioxidant-associated protective effect against coronary atherosclerosis
The comorbidity score was calculated based on the presence of diagnosis codes on medical claims in the pre-index period
The study tracked over 82,000 diabetes patients between 2014 and 2017
We look at the people who are facing these problems and think, well, it must be the insurance companies
1 REWIND reported lower stroke risk with dulaglutide, HR 0.76, 95% CI 0.61-0.95, P 0.01
